Gordon Ingle, Angel Investor

Accomplished Senior Medical Leader with 25+ years' experience in Clinical Development, Medical Affairs, and academia. Led all aspects of the clinical development program and built a global antibody-mediated rejection program in kidney transplantation from the ground up. As an Accredited Investor, I've leveraged my industry insights to make impactful private and public equity investments, with a 21% acquisition rate in my biotech portfolio. My track record also includes successful private equity angel investing in life sciences, medical diagnostics, and consumer products. As a senior leader in the pharmaceutical and biotechnology industry and as an investor, I am passionate about improving patient outcomes and advancing the field of medicine through innovative therapies and approaches. I am excited to continue leveraging my expertise in clinical development and medical affairs to drive positive change and make a meaningful impact on patients' lives.